Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,681 followers.

RT @FrontOncology: New research: Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?: Background In lung clin…

09 Oct 2023

Reply Repost Favourite

New research: Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?: Background In lung clinical trials with imaging, blinded independent central review with double reads is recommended to reduce evaluation bias and… #oncology h

08 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.